Literature DB >> 22948159

Constant domain-regulated antibody catalysis.

Gopal Sapparapu1, Stephanie Planque, Yukie Mitsuda, Gary McLean, Yasuhiro Nishiyama, Sudhir Paul.   

Abstract

Some antibodies contain variable (V) domain catalytic sites. We report the superior amide and peptide bond-hydrolyzing activity of the same heavy and light chain V domains expressed in the IgM constant domain scaffold compared with the IgG scaffold. The superior catalytic activity of recombinant IgM was evident using two substrates, a small model peptide that is hydrolyzed without involvement of high affinity epitope binding, and HIV gp120, which is recognized specifically by noncovalent means prior to the hydrolytic reaction. The catalytic activity was inhibited by an electrophilic phosphonate diester, consistent with a nucleophilic catalytic mechanism. All 13 monoclonal IgMs tested displayed robust hydrolytic activities varying over a 91-fold range, consistent with expression of the catalytic functions at distinct levels by different V domains. The catalytic activity of polyclonal IgM was superior to polyclonal IgG from the same sera, indicating that on average IgMs express the catalytic function at levels greater than IgGs. The findings indicate a favorable effect of the remote IgM constant domain scaffold on the integrity of the V-domain catalytic site and provide a structural basis for conceiving antibody catalysis as a first line immune function expressed at high levels prior to development of mature IgG class antibodies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948159      PMCID: PMC3476277          DOI: 10.1074/jbc.M112.401075

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.

Authors:  Rebecca A Rollett; Elizabeth J Wilkinson; David Gonzalez; James A L Fenton; Michael A Short; Paul A S Evans; Andy C Rawstron; Roger G Owen
Journal:  Clin Lymphoma Myeloma       Date:  2006-07

2.  Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.

Authors:  Jitra Kriangkum; Brian J Taylor; Steven P Treon; Michael J Mant; Tony Reiman; Andrew R Belch; Linda M Pilarski
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

Review 3.  The immunoglobulin constant region contributes to affinity and specificity.

Authors:  Marcela Torres; Arturo Casadevall
Journal:  Trends Immunol       Date:  2008-01-10       Impact factor: 16.687

4.  Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.

Authors:  Stephanie Planque; Yukie Mitsuda; Hiroaki Taguchi; Maria Salas; Mary-Kate Morris; Yasuhiro Nishiyama; Robert Kyle; Pablo Okhuysen; Miguel Escobar; Robert Hunter; Haynes W Sheppard; Carl Hanson; Sudhir Paul
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

Review 5.  Epigenetics of antigen-receptor gene assembly.

Authors:  Cornelis Murre
Journal:  Curr Opin Genet Dev       Date:  2007-10-24       Impact factor: 5.578

6.  Innate antibody catalysis.

Authors:  G Gololobov; M Sun; S Paul
Journal:  Mol Immunol       Date:  1999-12       Impact factor: 4.407

7.  Phosphonate ester probes for proteolytic antibodies.

Authors:  S Paul; A Tramontano; G Gololobov; Y X Zhou; H Taguchi; S Karle; Y Nishiyama; S Planque; S George
Journal:  J Biol Chem       Date:  2001-05-09       Impact factor: 5.157

8.  Catalytic features and eradication ability of antibody light-chain UA15-L against Helicobacter pylori.

Authors:  Emi Hifumi; Fumiko Morihara; Kenji Hatiuchi; Takuro Okuda; Akira Nishizono; Taizo Uda
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

9.  Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.

Authors:  Yukie Mitsuda; Stephanie Planque; Mariko Hara; Robert Kyle; Hiroaki Taguchi; Yasuhiro Nishiyama; Sudhir Paul
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

Review 10.  Exosites in the substrate specificity of blood coagulation reactions.

Authors:  P E Bock; P Panizzi; I M A Verhamme
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

View more
  9 in total

1.  Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.

Authors:  Stephanie A Planque; Yukie Mitsuda; Vida Chitsazzadeh; Santhi Gorantla; Larisa Poluektova; Yasuhiro Nishiyama; Christina Ochsenbauer; Mary-Kate Morris; Gopal Sapparapu; Carl V Hanson; Richard J Massey; Sudhir Paul
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

2.  A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.

Authors:  Anthony Bowen; Maggie P Wear; Radames J B Cordero; Stefan Oscarson; Arturo Casadevall
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

3.  Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences.

Authors:  Alena Janda; Ertan Eryilmaz; Antonio Nakouzi; Mary Ann Pohl; Anthony Bowen; Arturo Casadevall
Journal:  J Biol Chem       Date:  2015-03-16       Impact factor: 5.157

4.  Anti-DNA antibody mediated catalysis is isotype dependent.

Authors:  Yumin Xia; Ertan Eryilmaz; Qiuting Zhang; David Cowburn; Chaim Putterman
Journal:  Mol Immunol       Date:  2015-12-01       Impact factor: 4.407

5.  Metal-dependent amyloid β-degrading catalytic antibody construct.

Authors:  Yasuhiro Nishiyama; Hiroaki Taguchi; Mariko Hara; Stephanie A Planque; Yukie Mitsuda; Sudhir Paul
Journal:  J Biotechnol       Date:  2014-04-01       Impact factor: 3.307

6.  Physiological IgM class catalytic antibodies selective for transthyretin amyloid.

Authors:  Stephanie A Planque; Yasuhiro Nishiyama; Mariko Hara; Sari Sonoda; Sarah K Murphy; Kenji Watanabe; Yukie Mitsuda; Eric L Brown; Richard J Massey; Stanley R Primmer; Brian O'Nuallain; Sudhir Paul
Journal:  J Biol Chem       Date:  2014-03-19       Impact factor: 5.157

7.  CD4 binding determinant mimicry for HIV vaccine design.

Authors:  Yasuhiro Nishiyama; Stephanie Planque; Carl V Hanson; Richard J Massey; Sudhir Paul
Journal:  Front Immunol       Date:  2012-12-17       Impact factor: 7.561

8.  Role of κ→λ light-chain constant-domain switch in the structure and functionality of A17 reactibody.

Authors:  Natalia Ponomarenko; Spyros D Chatziefthimiou; Inna Kurkova; Yuliana Mokrushina; Yuliana Mokrushina; Anastasiya Stepanova; Ivan Smirnov; Marat Avakyan; Tatyana Bobik; Azad Mamedov; Vladimir Mitkevich; Alexey Belogurov; Olga S Fedorova; Michael Dubina; Andrey Golovin; Victor Lamzin; Alain Friboulet; Alexander A Makarov; Matthias Wilmanns; Alexander Gabibov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-15

9.  Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States.

Authors:  Evgeny A Ermakov; Georgy A Nevinsky; Valentina N Buneva
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.